Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)

计划入组 30 人 · 首次发布于 2022 年 11 月 14 日

Imaging the HIV Reservoir

计划入组 17 人 · 首次发布于 2017 年 2 月 24 日

64Cu-GRIP B in Patients With Advanced Malignancies

计划入组 91 人 · 首次发布于 2023 年 6 月 5 日

64Cu-DOTA-AE105

64Cu-DOTHA2-PSMA

copper-64-ATV:4D9

Southern Copper

Vizsla Copper Corp

Western Copper & Gold

Clarity Pharmaceuticals Secures Large-Scale Copper-64 Manufacturing Agreement with Theragenics for Prostate Cancer Diagnostic

Nusano Secures Major Supply Agreements with Ratio Therapeutics and Clarity Pharmaceuticals to Address Critical Radioisotope Shortage

Clarity Pharmaceuticals Secures Major Manufacturing Deal to Scale Cu-SAR-bisPSMA Production for Prostate Cancer Diagnostics